Opinion/decision on a Paediatric investigation plan (PIP): Odevixibat, decision type: , therapeutic area: , PIP number: P/0515/2022
Opinion/decision on a Paediatric investigation plan (PIP): Entospletinib, decision type: , therapeutic area: , PIP number: P/0518/2022
Opinion/decision on a Paediatric investigation plan (PIP): Xenleta,Lefamulin, decision type: , therapeutic area: , PIP number: P/0535/2022
Network Portfolio
Biosimilar medicines: Overview
Biosimilars in the EU - Information guide for healthcare professionals
Opinion/decision on a Paediatric investigation plan (PIP): Sirturo,bedaquiline fumarate, decision type: , therapeutic area: , PIP number: P/0470/2022
Template for scientific document (part B-F)
Medicinal products for human use: monthly figures - October 2023
Procurement